STOCKHOLDERS' DEFICIT (Tables)

3 Months Ended

Mar. 31, 2026

Schedule of Share-Based Payment Arrangement, Cost by Plan

The following table presents the Company's total share-based compensation expense by award type:


(In thousands)	Three Months Ended March 31,
	2026		2025
RSUs	$	3,122	$	5,328
Performance RSUs	(2,763)		3,529
Options	—		172
Total Share-Based Compensation Expense(1)	$	359	$	9,029

(1)Total share-based compensation expense includes $(3.3) million and $1.6 million of expense from cash-settled awards for the three months ended March 31, 2026 and March 31, 2025, respectively. The reduction in share-based compensation recognized in 2026 is due to changes in the Company’s stock price during the first quarter of 2026, resulting in lower expense associated with cash-settled awards.

Schedule of Computation of Loss per Share

Computation of Loss per Share


(In thousands, except per share data)	Three Months Ended March 31,
	2026		2025
NUMERATOR:
Net loss attributable to the Company – common shares	$	(95,223)	$	(281,224)

DENOMINATOR(1):
Weighted average common shares outstanding - basic	155,789		152,480
Stock options and restricted stock(2):	—		—
Weighted average common shares outstanding - diluted	155,789		152,480

Net loss attributable to the Company per common share:
Basic	$	(0.61)	$	(1.84)
Diluted	(0.61)		(1.84)

(1)All of the outstanding Class B common stock and Special Warrants are included in both the basic and diluted weighted average common shares outstanding of the Company for the three months ended March 31, 2026 and 2025.

(2)Outstanding equity service awards representing 13.0 million and 16.6 million shares of Class A common stock of the Company for the three months ended March 31, 2026 and 2025, respectively, were not included in the computation of diluted earnings per share because to do so would have been antidilutive.